Stages of change for adherence to antiretroviral medications

AIDS Patient Care and STDs

Volumn 27, Issue 10, 2013, Pages 567-572

  Genberg, Becky L ^a   Lee, Yoojin ^a   Rogers, William H ^b   Willey, Cynthia ^c   Wilson, Ira B ^a  

^a BROWN UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; VIRUS LOAD; AGED; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERVENTION STUDY; INTERVIEW; MIDDLE AGED; PSYCHOLOGICAL MODEL; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SOCIOECONOMICS; VIROLOGY; YOUNG ADULT;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERVENTION STUDIES; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84885232972     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0126     Document Type: Article

References (27)

1. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183. (Pubitemid 32549871)
2. Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med 2002;17:1-11. (Pubitemid 34117786)
3. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991;59:295-304.
4. Willey C. Behavior-changing methods for improving adherence to medication. Curr Hypertens Rep 1999;1:477-481.
5. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997;12:38-48. (Pubitemid 27382892)
6. Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure. Clin Ther 2000;22:858-871. (Pubitemid 30625918)
7. Highstein GR, Willey C, Mundy LM. Development of stage of readiness and decisional balance instruments: Tools to enhance clinical decision-making for adherence to antiretroviral therapy. AIDS Behav 2006;10:563-573. (Pubitemid 44285077)
8. Wilson IB, Laws MB, Safren SA, et al. Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr 2010;53:338-347.
9. Ware J,Jr, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233. (Pubitemid 126433231)
10. Rogers WH, Wilson IB, Bungay KM, Cynn DJ, Adler DA. Assessing the performance of a new depression screener for primary care (PC-SAD). J Clin Epidemiol 2002;55:164-175. (Pubitemid 34051530)
11. Tamburrino MB, Nagel RW, Chahal MK, Lynch DJ. Antidepressant medication adherence: A study of primary care patients. J Clin Psychiatry 2009;11:205-211.
12. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; CD000011.
13. Galarraga O, Genberg BL, Martin RA, Barton Laws M, Wilson IB. Conditional economic incentives to improve HIV treatment adherence: Literature review and theoretical considerations. AIDS Behav 2013;17:2283-2292.
14. Defulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med 2012;55:S86-S94.
15. Velicer WF, Prochaska JO, Bellis JM, et al. An expert system intervention for smoking cessation. Addict Behav 1993; 18:269-290. (Pubitemid 23184343)
16. Willey C, Laforge R, Blais L, Pallonen U, Prochaska J, Botelho R. Public health and the science of behavior change. Curr Issues Public Health 1996;2:18-25.
17. Brug J, Conner M, Harre N, Kremers S, McKellar S, Whitelaw S. The transtheoretical model and stages of change: A critique: Observations by five commentators on the paper by Adams, J. and White, M. (2004) Why don't stage-based activity promotion interventions work? Health Educ Res 2005;20:244-258. (Pubitemid 40461481)
18. Steiner JF. Rethinking adherence. Ann Intern Med 2012;157: 580-585.
19. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30. (Pubitemid 30432540)
20. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr 2002;31:S123-S127. (Pubitemid 35453571)
21. Flaks RC, Burman WJ, Gourley PJ, Rietmeijer CA, Cohn DL. HIV transmission risk behavior and its relation to antiretroviral treatment adherence. Sex Transm Dis. 2003;30: 399-404. (Pubitemid 36605488)
22. Kalichman SC, Cherry C, Amaral CM, et al. Adherence to antiretroviral therapy and HIV transmission risks: Implications for test-and-treat approaches to HIV prevention. AIDS Patient Care STDS 2010;24:271-277.
23. Diamond C, Richardson JL, Milam J, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J Acquir Immune Defic Syndr 2005;39:211-218. (Pubitemid 40741121)
24. Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr 2004;35:503-510. (Pubitemid 38420659)
25. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001;28:445-449. (Pubitemid 34033195)
26. Roberts KJ, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care 2000;12:377-386. (Pubitemid 30618182)
27. Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35:1010-1015. (Pubitemid 32880016)